Drug-drug interactions with tyrosine kinase inhibitors

被引：0
作者：
Janus, N. [1 ]
机构：
[1] LEO Pharma, Global Med Affairs, Voisins Le Bretonneaux, France
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1926
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1623P
引用
收藏
页码：S1283 / S1283
页数：1
相关论文
共 50 条
[31]   Comparative review of drug-drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer [J].
Xu, Zi-Yi ;
Li, Jun-Ling .
ONCOTARGETS AND THERAPY, 2019, 12 :5467-5484
[32]   Tyrosine kinase inhibitors and direct oral anticoagulants: In vitro evaluation of drug-drug interaction mediated by P-glycoprotein [J].
Lafaie, Ludovic ;
Hodin, Sophie ;
Saib, Sonia ;
Bin, Valerie ;
Bertoletti, Laurent ;
Delavenne, Xavier .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 (05) :860-868
[33]   Drug interactions with Bruton's tyrosine kinase inhibitors: clinical implications and management [J].
Fancher, Karen M. ;
Pappacena, Jeremy J. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (04) :507-515
[34]   Drug interactions with Bruton’s tyrosine kinase inhibitors: clinical implications and management [J].
Karen M. Fancher ;
Jeremy J. Pappacena .
Cancer Chemotherapy and Pharmacology, 2020, 86 :507-515
[35]   Dipeptidylpeptidase-4 Inhibitors (Gliptins)Focus on Drug-Drug Interactions [J].
André J. Scheen .
Clinical Pharmacokinetics, 2010, 49 :573-588
[36]   Dipeptidylpeptitase-4 Inhibitors (Gliptins) Focus on Drug-Drug Interactions [J].
Scheen, Andre J. .
CLINICAL PHARMACOKINETICS, 2010, 49 (09) :573-588
[37]   mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions [J].
Fernandes-Silva, Gabriel ;
de Paula, Mayara Ivani ;
Rangel, Erika B. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (04) :367-385
[38]   Potential drug-drug interactions with mitogen-activated protein kinase (MEK) inhibitors used to treat melanoma [J].
Marani, A. ;
Gioacchini, H. ;
Paolinelli, M. ;
Offidani, A. ;
Campanati, A. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (08) :555-567
[39]   Therapeutic drug monitoring and tyrosine kinase inhibitors [J].
Herviou, Pauline ;
Thivat, Emilie ;
Richard, Damien ;
Roche, Lucie ;
Dohou, Joyce ;
Pouget, Melanie ;
Eschalier, Alain ;
Durando, Xavier ;
Authier, Nicolas .
ONCOLOGY LETTERS, 2016, 12 (02) :1223-1232
[40]   COCAINE DRUG-DRUG INTERACTIONS [J].
ROSEN, EH .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1992, 12 (06) :445-445
12345